{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:23:11Z","timestamp":1787998991093,"version":"build-2784847793"},"reference-count":171,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.survophthal.2025.06.009","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:53:59Z","timestamp":1750276439000},"page":"483-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Advances in diagnosing and treating giant cell arteritis: New hope for arteritic anterior ischemic optic neuropathy"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2630-3732","authenticated-orcid":false,"given":"Leon","family":"von der Emde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Petzinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina C.","family":"Herwig-Carl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike S.","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Juergen","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Isaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Terheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin S.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6583-8283","authenticated-orcid":false,"given":"Thomas","family":"Ach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13075-021-02450-w","article-title":"A meta-analysis of the epidemiology of giant cell arteritis across time and space","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"22","key":"10.1016\/j.survophthal.2025.06.009_bib2","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.survophthal.2025.06.009_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","article-title":"Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities","volume":"13","author":"Dejaco","year":"2017","journal-title":"Nat Rev Rheuma"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib4","doi-asserted-by":"crossref","first-page":"ITC65","DOI":"10.7326\/AITC201611010","article-title":"Giant cell arteritis","volume":"165","author":"Hoffman","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003379","article-title":"Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations","volume":"9","author":"Bosch","year":"2023","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2217\/ahe.11.50","article-title":"Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly","volume":"7","author":"Dejaco","year":"2011","journal-title":"Aging Health"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib8","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatol (Oxf)"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/art.21075","article-title":"Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"2 89","key":"10.1016\/j.survophthal.2025.06.009_bib11","article-title":"Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study","volume":"33","author":"Patil","year":"2015","journal-title":"Clin Exp Rheuma"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","journal-title":"J Rheuma"},{"key":"10.1016\/j.survophthal.2025.06.009_bib13","article-title":"Giant Cell Arteritis Presenting With Ocular Symptoms: Clinical Characteristics and Multimodal Imaging in a Chinese Case Series","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"25","key":"10.1016\/j.survophthal.2025.06.009_bib14","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1056\/NEJMra1413352","article-title":"Ischemic optic neuropathies","volume":"372","author":"Biousse","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.survophthal.2025.06.009_bib15","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1007\/s00330-023-09770-2","article-title":"Orbital magnetic resonance imaging of giant cell arteritis with ocular manifestations: a systematic review and individual participant data meta-analysis","volume":"33","author":"Guggenberger","year":"2023","journal-title":"Eur Radio"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MD.0000000000000033","article-title":"Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients","volume":"93","author":"Alba","year":"2014","journal-title":"Med (Baltim)"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib17","first-page":"171","article-title":"Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis","volume":"19","author":"Hachulla","year":"2001","journal-title":"Clin Exp Rheuma"},{"issue":"7","key":"10.1016\/j.survophthal.2025.06.009_bib18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3899\/jrheum.141347","article-title":"Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study","volume":"42","author":"Kermani","year":"2015","journal-title":"J Rheuma"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of Tocilizumab in Giant-Cell Arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"10031","key":"10.1016\/j.survophthal.2025.06.009_bib20","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.survophthal.2025.06.009_bib21","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.survophthal.2025.06.009_bib22","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/CIRCULATIONAHA.117.030423","article-title":"Inhibition of JAK-STAT signaling suppresses pathogenic immune responses in medium and large vessel vasculitis","volume":"137","author":"Zhang","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/annrheumdis-2015-208371","article-title":"Blocking interferon \u03b3 reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis","volume":"75","author":"Corbera-Bellalta","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2025.06.009_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fimmu.2018.00809","article-title":"Expression and Function of IL12\/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways","volume":"9","author":"Esp\u00edgol-Frigol\u00e9","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13075-019-2068-7","article-title":"Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis","volume":"21","author":"Matsumoto","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.survophthal.2025.06.009_bib26","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3389\/fimmu.2019.01638","article-title":"Decreased expression of negative immune checkpoint VISTA by CD4+ T cells facilitates T Helper 1, T Helper 17, and T follicular helper lineage differentiation in GCA","volume":"10","author":"Hid Cadena","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103328","article-title":"The role of autoimmunity and autoinflammation in giant cell arteritis: a systematic literature review","volume":"22","author":"Sch\u00e4fer","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"399","key":"10.1016\/j.survophthal.2025.06.009_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3322","article-title":"The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway","volume":"9","author":"Wen","year":"2017","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib29","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/art.34327","article-title":"Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis","volume":"64","author":"Terrier","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10067-018-4240-x","article-title":"Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-na\u00efve patients","volume":"38","author":"Burja","year":"2019","journal-title":"Clin Rheuma"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/annrheumdis-2016-210070","article-title":"An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy","volume":"76","author":"Miyabe","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20110340","article-title":"IL-6\/IL-6 receptor system and its role in physiological and pathological conditions","volume":"122","author":"Mihara","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.survophthal.2025.06.009_bib35","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/rheumatology\/ker163","article-title":"Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study","volume":"50","author":"Visvanathan","year":"2011","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.survophthal.2025.06.009_bib36","unstructured":"Gupta M., Ireland A.C., Bordoni B. StatPearls: Neuroanatomy, Visual Pathway. Treasure Island (FL); 2023."},{"key":"10.1016\/j.survophthal.2025.06.009_bib37","unstructured":"Gupta N., Motlagh M., Singh G. StatPearls: Anatomy, Head and Neck, Eye Arteries. Treasure Island (FL); 2023."},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib38","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1038\/s41598-017-10042-5","article-title":"Location of the central retinal vessel trunk in the laminar and prelaminar tissue of healthy and glaucomatous eyes","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/bjo.40.2.65","article-title":"Anastomoses between the retinal and ciliary arterial circulations","volume":"40","author":"WYBAR","year":"1956","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib40","first-page":"1240","article-title":"Optic nerve sheath diameters in healthy adults measured by computer tomography","volume":"8","author":"Vaiman","year":"2015","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5858\/arpa.2016-0027-RS","article-title":"Pathology of ischemic optic neuropathy","volume":"141","author":"Patel","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10384-015-0373-5","article-title":"Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses","volume":"59","author":"Bernstein","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.06.009_bib43","first-page":"221","article-title":"Histopathologic studies of ischemic optic neuropathy","volume":"98","author":"Knox","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2025.06.009_bib44","first-page":"47","article-title":"Papilledema: epidemiology, etiology, and clinical management","volume":"7","author":"Rigi","year":"2015","journal-title":"Eye Brain"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","article-title":"Ischemic optic neuropathy","volume":"28","author":"Hayreh","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2025.06.009_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.04.001","article-title":"Ocular vascular occlusive disorders: natural history of visual outcome","volume":"41","author":"Hayreh","year":"2014","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib47","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","article-title":"Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis","volume":"123","author":"Chen","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.survophthal.2025.06.009_bib48","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00417-013-2399-z","article-title":"Ischemic optic neuropathies - where are we now?","volume":"251","author":"Hayreh","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/0301-4738.77024","article-title":"Management of ischemic optic neuropathies","volume":"59","author":"Hayreh","year":"2011","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.06.009_bib50","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archopht.123.11.1554","article-title":"Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination","volume":"123","author":"Hayreh","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.06.009_bib51","article-title":"Color vision in anterior ischemic optic neuropathy","volume":"19","author":"Pollock","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib52","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?","volume":"55","author":"Diamantopoulos","year":"2016","journal-title":"Rheumatol (Oxf)"},{"issue":"_2","key":"10.1016\/j.survophthal.2025.06.009_bib55","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1093\/rheumatology\/kex461","article-title":"Ultrasound in the diagnosis and management of giant cell arteritis","volume":"57","author":"Schmidt","year":"2018","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.survophthal.2025.06.009_bib56","article-title":"Fast-track ultrasound clinic for the diagnosis of giant cell arteritis changes the prognosis of the disease but not the risk of future relapse","volume":"7","author":"Monti","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.survophthal.2025.06.009_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/s00393-024-01519-6","article-title":"Empfehlungen zur Definition von Riesenzellarteriitis-Fast-Track-Kliniken","author":"Schmidt","year":"2024","journal-title":"Z Rheuma"},{"key":"10.1016\/j.survophthal.2025.06.009_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/s00393-024-01565-0","article-title":"Neues in der Bildgebung von Gro\u00dfgef\u00e4\u00dfvaskulitiden","author":"Sch\u00e4fer","year":"2024","journal-title":"Z Rheuma"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib59","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/S2665-9913(24)00027-4","article-title":"Development of a diagnostic prediction model for giant cell arteritis by sequential application of southend giant cell arteritis probability score and ultrasonography: a prospective multicentre study","volume":"6","author":"Sebastian","year":"2024","journal-title":"Lancet Rheuma"},{"issue":"8","key":"10.1016\/j.survophthal.2025.06.009_bib60","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/art.40876","article-title":"Glucocorticoid dosages and acute-phase reactant levels at giant cell arteritis flare in a randomized trial of tocilizumab","volume":"71","author":"Stone","year":"2019","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.survophthal.2025.06.009_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120222","article-title":"Ischemic ocular manifestations of giant cell arteritis: a Canadian case series","volume":"436","author":"Issa","year":"2022","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: ocular manifestations","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11926-021-00980-5","article-title":"Blood biomarkers for monitoring and prognosis of large vessel vasculitides","volume":"23","author":"Tombetti","year":"2021","journal-title":"Curr Rheuma Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003397","article-title":"New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis","volume":"10","author":"Tomelleri","year":"2024","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.survophthal.2025.06.009_bib65","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib66","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib67","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.semarthrit.2021.04.014","article-title":"OMERACT definition and reliability assessment of chronic ultrasound lesions of the axillary artery in giant cell arteritis","volume":"51","author":"Sch\u00e4fer","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib68","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/rheumatology\/kex289","article-title":"Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis","volume":"56","author":"Sch\u00e4fer","year":"2017","journal-title":"Rheumatol (Oxf)"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib69","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3899\/jrheum.171428","article-title":"Assessing vasculitis in giant cell arteritis by ultrasound: results of OMERACT patient-based reliability exercises","volume":"45","author":"Sch\u00e4fer","year":"2018","journal-title":"J Rheuma"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib70","first-page":"47","article-title":"Temporal artery compression sign--a novel ultrasound finding for the diagnosis of giant cell arteritis","volume":"34","author":"Aschwanden","year":"2013","journal-title":"Ultraschall Med"},{"issue":"11","key":"10.1016\/j.survophthal.2025.06.009_bib71","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/annrheumdis-2021-220306","article-title":"Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis","volume":"80","author":"Ponte","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2025.06.009_bib72","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X21998505","article-title":"Ultrasound for diagnosis and follow-up of chronic axillary vasculitis in patients with long-standing giant cell arteritis","volume":"13","author":"Bosch","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib73","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard-2022-223367","article-title":"The provisional OMERACT ultrasonography score for giant cell arteritis","volume":"82","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2025.06.009_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.01.018","article-title":"The giant cell arteritis (GCA) ultrasound score (OGUS) at diagnosis and after initial treatment predicts future relapses in GCA patients: results of a multicentre prospective study","author":"Monti","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib75","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/rheumatology\/keae287","article-title":"Transorbital ultrasound in the diagnosis of giant cell arteritis","volume":"63","author":"Petzinna","year":"2024","journal-title":"Rheumatol (Oxf)"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00296-025-05800-y","article-title":"Imaging of ophthalmic manifestations: optical coherence tomography angiography and transorbital ultrasound in giant cell arteritis","volume":"45","author":"Petzinna","year":"2025","journal-title":"Rheuma Int"},{"issue":"ement_1","key":"10.1016\/j.survophthal.2025.06.009_bib77","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1093\/rheumatology\/keae487","article-title":"Biopsy vs imaging in the diagnosis of giant cell arteritis. Viewpoint 1: in favour of imaging","volume":"64","author":"Schmidt","year":"2025","journal-title":"Rheumatol (Oxf)"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"ement_1","key":"10.1016\/j.survophthal.2025.06.009_bib79","doi-asserted-by":"crossref","first-page":"i74","DOI":"10.1093\/rheumatology\/keae474","article-title":"Biopsy vs imaging for the diagnosis of giant cell arteritis. Viewpoint 2: in favour of biopsy","volume":"64","author":"Esp\u00edgol-Frigol\u00e9","year":"2025","journal-title":"Rheumatol (Oxf)"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jcp.53.2.137","article-title":"MJ. The importance of skip lesions in temporal arteritis","volume":"53","author":"van Wyk","year":"2000","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib81","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/acr.24393","article-title":"Association between specimen length and number of sections and diagnostic yield of temporal artery biopsy for giant cell arteritis","volume":"73","author":"Muratore","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib82","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jcp.53.2.131","article-title":"Franks AJ. Temporal artery biopsy: is there any value in examining biopsies at multiple levels?","volume":"53","author":"Chakrabarty","year":"2000","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib83","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/03009742.2016.1196501","article-title":"Association between specimen length and diagnostic yield of temporal artery biopsy","volume":"46","author":"Grossman","year":"2017","journal-title":"Scand J Rheuma"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib84","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCRESAHA.122.322128","article-title":"Immunology of giant cell arteritis","volume":"132","author":"Weyand","year":"2023","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.survophthal.2025.06.009_bib85","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/PAS.0000000000000244","article-title":"Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations","volume":"38","author":"Cavazza","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib86","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1755-3768.1994.tb02766.x","article-title":"Temporal arteritis. Comparison of histological and clinical findings","volume":"72","author":"Schmidt","year":"1994","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.06.009_bib87","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2016.03.005","article-title":"Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis","volume":"69","author":"Muratore","year":"2016","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/art.33362","article-title":"Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis","volume":"64","author":"Restuccia","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2025.06.009_bib89","article-title":"Updates on the diagnosis and monitoring of giant cell arteritis","volume":"10","author":"Monti","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib90","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/rheumatology\/kez385","article-title":"Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis","volume":"59","author":"Rubenstein","year":"2020","journal-title":"Rheumatol (Oxf)"},{"issue":"90","key":"10.1016\/j.survophthal.2025.06.009_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The Role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol Assess"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib92","article-title":"Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis","volume":"2","author":"Pouncey","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.survophthal.2025.06.009_bib93","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheuma"},{"issue":"12","key":"10.1016\/j.survophthal.2025.06.009_bib94","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/jcp.2010.079426","article-title":"An elastic Van Gieson stain is unnecessary for the histological diagnosis of giant cell temporal arteritis","volume":"63","author":"Foss","year":"2010","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib95","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.survophthal.2025.06.009_bib96","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keae056","article-title":"MRVAS Score-introducing a standardized magnetic resonance scoring system for assessing the extent of inflammatory burden in giant cell arteritis","author":"Froehlich","year":"2024","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.survophthal.2025.06.009_bib97","article-title":"High-resolution magnetic resonance imaging visualizes intracranial large artery involvement in giant cell arteritis","author":"Guggenberger","year":"2024","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.survophthal.2025.06.009_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2023-eular.7009","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.survophthal.2025.06.009_bib99","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2011-200865","article-title":"Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography","volume":"71","author":"Prieto-Gonz\u00e1lez","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib100","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000486","article-title":"Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study","volume":"94","author":"Prieto-Gonz\u00e1lez","year":"2015","journal-title":"Med (Baltim)"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib101","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcct.2013.08.009","article-title":"CT angiographic imaging characteristics of thoracic idiopathic aortitis","volume":"7","author":"Chowdhary","year":"2013","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11030236","article-title":"A review on the value of imaging in differentiating between large vessel vasculitis and atherosclerosis","volume":"11","author":"Nienhuis","year":"2021","journal-title":"J Pers Med"},{"issue":"7","key":"10.1016\/j.survophthal.2025.06.009_bib103","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC","volume":"45","author":"Slart","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.survophthal.2025.06.009_bib104","first-page":"1551","article-title":"FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models","volume":"42","author":"Mochizuki","year":"2001","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-018-4106-0","article-title":"Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET\/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study","volume":"46","author":"Nielsen","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib106","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/art.40379","article-title":"18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis","volume":"70","author":"Grayson","year":"2018","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.survophthal.2025.06.009_bib107","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejim.2017.08.013","article-title":"Repetitive 18F-FDG-PET\/CT in patients with large-vessel giant-cell arteritis and controlled disease","volume":"46","author":"Boysson","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.survophthal.2025.06.009_bib108","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1007\/s00259-021-05362-8","article-title":"Diagnostic value of 18FFDG-PET\/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis","volume":"48","author":"van der Geest","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.survophthal.2025.06.009_bib109","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.survophthal.2025.06.009_bib110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11926-020-00955-y","article-title":"Imaging for diagnosis, monitoring, and outcome prediction of large vessel vasculitides","volume":"22","author":"Sch\u00e4fer","year":"2020","journal-title":"Curr Rheuma Rep"},{"key":"10.1016\/j.survophthal.2025.06.009_bib111","article-title":"Comparison of 18FFAPI-42 and 18FFDG PET\/CT in the evaluation of systemic vasculitis","author":"Zhong","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"10.1016\/j.survophthal.2025.06.009_bib112","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2010-09-311076","article-title":"Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer","volume":"118","author":"Aalto","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2025.06.009_bib113","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13075-015-0826-8","article-title":"68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitis","volume":"17","author":"Virtanen","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib114","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1024\/0301-1526\/a001031","article-title":"Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases","volume":"51","author":"Danielli","year":"2022","journal-title":"Vasa"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/ars.2017.7418","article-title":"Vascular adhesion protein-1: a cell surface amine oxidase in translation","volume":"30","author":"Salmi","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.survophthal.2025.06.009_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1501790","article-title":"Case report: detecting giant cell arteritis in [68Ga]Ga-DOTA-Siglec-9-PET\/CT","volume":"15","author":"Petzinna","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.survophthal.2025.06.009_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1448157","article-title":"Vascular-adhesion protein 1 in giant cell arteritis and polymyalgia rheumatica","volume":"11","author":"Petzinna","year":"2024","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib118","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/WNO.0000000000001358","article-title":"Detection of optic disc abnormalities in color fundus photographs using deep learning","volume":"41","author":"Liu","year":"2021","journal-title":"J Neuroophthalmol"},{"issue":"96","key":"10.1016\/j.survophthal.2025.06.009_bib119","first-page":"71","article-title":"Differential diagnoses of the pale\/white\/atrophic disc","volume":"29","author":"Osaguona","year":"2016","journal-title":"Community Eye Health"},{"key":"10.1016\/j.survophthal.2025.06.009_bib120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/aes.2019.12.05","article-title":"Optical coherence tomography in ischemic optic neuropathy","volume":"5","author":"Fard","year":"2020","journal-title":"Ann Eye Sci"},{"key":"10.1016\/j.survophthal.2025.06.009_bib121","first-page":"8","article-title":"Explainabilty of a deep learning system able to accurately detect arteritic anterior ischemic optic neuropathy from giant cell arteritis on fundus photographs","volume":"2023","author":"Dan","year":"1874","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22135-x","article-title":"Measurement of retinal nerve fiber layer thickness with a deep learning algorithm in ischemic optic neuropathy and optic neuritis","volume":"12","author":"Razaghi","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib123","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12886-025-03997-x","article-title":"Biomarkers of ocular manifestation in newly diagnosed giant cell arteritis","volume":"25","author":"Terheyden","year":"2025","journal-title":"BMC Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib124","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1167\/iovs.07-0171","article-title":"Mu\u00f1oz-Negrete FJ. Optic disc evaluation by optical coherence tomography in nonarteritic anterior ischemic optic neuropathy","volume":"48","author":"Contreras","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2025.06.009_bib125","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2147\/OPTH.S42522","article-title":"Long-term retinal nerve fiber layer changes following nonarteritic anterior ischemic optic neuropathy","volume":"7","author":"Dotan","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib126","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ajo.2006.09.045","article-title":"Correlations between retinal nerve fiber layer and visual field in eyes with nonarteritic anterior ischemic optic neuropathy","volume":"143","author":"Dele\u00f3n-Ortega","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib127","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1111\/j.1755-3768.2012.02467.x","article-title":"Macular thickness predictive of visual field sensitivity in ischaemic optic neuropathy","volume":"90","author":"Papchenko","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib128","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1167\/iovs.14-15314","article-title":"Mu\u00f1oz-Negrete FJ. Papillomacular bundle and inner retinal thicknesses correlate with visual acuity in nonarteritic anterior ischemic optic neuropathy","volume":"56","author":"Rebolleda","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2025.06.009_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8963267","article-title":"Bruch's membrane opening minimum rim width measurement with SD-OCT: a method to correct for the opening size of Bruch's membrane","volume":"2017","author":"Kromer","year":"2017","journal-title":"J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/01658107.2019.1650075","article-title":"Bruch's membrane opening minimum rim width in the differential diagnosis of optic neuropathies","volume":"44","author":"Braga","year":"2020","journal-title":"Neuroophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib131","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/1120672118782101","article-title":"Lamina cribrosa position and Bruch's membrane opening differences between anterior ischemic optic neuropathy and open-angle glaucoma","volume":"29","author":"Rebolleda","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib132","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3341\/kjo.1999.13.2.100","article-title":"Fluorescein angiographic features of choroidal insufficiency in anterior ischemic optic neuropathy","volume":"13","author":"Shin","year":"1999","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.06.009_bib133","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2147\/OPTH.S112196","article-title":"Acute vision loss and choroidal filling delay in the absence of giant-cell arteritis","volume":"10","author":"Bei","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib134","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00006982-199902000-00008","article-title":"Indocyanine green versus fluorescein angiography in the differential diagnosis of arteritic and nonarteritic anterior ischemic optic neuropathy","volume":"19","author":"Valmaggia","year":"1999","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/2474126418771805","article-title":"Imaging the deep choroidal vasculature using spectral domain and swept source optical coherence tomography angiography","volume":"2","author":"Diaz","year":"2018","journal-title":"J Vitreoretin Dis"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41377-022-00740-9","article-title":"Towards standardizing retinal optical coherence tomography angiography: a review","volume":"11","author":"Sampson","year":"2022","journal-title":"Light Sci Appl"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib137","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/tjo.tjo_55_21","article-title":"The current clinical role of optical coherence tomography angiography in neuro-ophthalmological diseases","volume":"12","author":"Bilici","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib138","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/11206721221113681","article-title":"Optical coherence tomography angiography (OCT angiography) in anterior ischemic optic neuropathy (AION): A systematic review and meta-analysis","volume":"33","author":"Khalili","year":"2023","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib139","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/2008-322X.200162","article-title":"Optical coherence tomography angiography of the optic disc; an overview","volume":"12","author":"Akil","year":"2017","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.survophthal.2025.06.009_bib140","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-022-02673-8","article-title":"Superficial capillary plexus vessel density\/deep capillary plexus vessel density ratio in healthy eyes","volume":"22","author":"Nam","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041094","article-title":"Vessel density and vessel tortuosity quantitative analysis of arteritic and non-arteritic anterior ischemic optic neuropathies: an optical coherence tomography angiography study","volume":"9","author":"Pierro","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2025.06.009_bib142","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajo.2016.07.023","article-title":"Choriocapillaris flow features follow a power law distribution: implications for characterization and mechanisms of disease progression","volume":"170","author":"Spaide","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.06.009_bib143","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2019.03.028","article-title":"Choroidal vascular changes in arteritic and nonarteritic anterior ischemic optic neuropathy","volume":"205","author":"Pellegrini","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.06.009_bib144","unstructured":"Aliza, Epstein Ekhlassi, Timothy Faia, Lisa Black, Evan Edited By: Scott, Ingrid U. Fekrat, Sharon. \u3008https:\/\/www.aao.org\/eyenet\/article\/giant-cell-arteritis-a-review\u3009."},{"issue":".3","key":"10.1016\/j.survophthal.2025.06.009_bib145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00393-020-00893-1","article-title":"S2k-Leitlinie: management der Gro\u00dfgef\u00e4\u00dfvaskulitiden","volume":"79","author":"Schirmer","year":"2020","journal-title":"Z Rheuma"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib146","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kez672","article-title":"British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis","volume":"59","author":"Mackie","year":"2020","journal-title":"Rheumatol (Oxf)"},{"issue":"12","key":"10.1016\/j.survophthal.2025.06.009_bib147","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/s41433-023-02433-y","article-title":"Giant cell arteritis: reviewing the advancing diagnostics and management","volume":"37","author":"Bilton","year":"2023","journal-title":"Eye (Lond)"},{"issue":"02","key":"10.1016\/j.survophthal.2025.06.009_bib148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/a-2214-5030","article-title":"Neue Ans\u00e4tze in der immunologischen Therapie der Riesenzellarteriitis und Polymyalgia rheumatica","volume":"44","author":"Petzinna","year":"2024","journal-title":"Arthritis und Rheuma"},{"key":"10.1016\/j.survophthal.2025.06.009_bib149","unstructured":"Schirmer J.H., Aries P.M., Balzer K., et al. S2k-Leitlinie Management der Gro\u00dfgef\u00e4\u00dfvaskulitiden. 2020, Im Internet: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/060-007, Stand: 09.03.2023."},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2016.05.009","article-title":"Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis","volume":"46","author":"Broder","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib151","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00296-017-3874-3","article-title":"Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database","volume":"38","author":"Albrecht","year":"2018","journal-title":"Rheuma Int"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib152","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.45.2.136","article-title":"Azathioprine in giant cell arteritis\/polymyalgia rheumatica: a double-blind study","volume":"45","author":"Silva","year":"1986","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.survophthal.2025.06.009_bib153","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10067-018-4232-x","article-title":"Does leflunomide have a role in giant cell arteritis? An open-label study","volume":"38","author":"Ho\u010devar","year":"2019","journal-title":"Clin Rheuma"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib154","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semarthrit.2012.12.023","article-title":"Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review","volume":"43","author":"Boysson","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib155","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/art.40037","article-title":"A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of takayasu arteritis","volume":"69","author":"Langford","year":"2017","journal-title":"Arthritis Rheuma"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib156","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib157","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Mart\u00ednez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.survophthal.2025.06.009_bib158","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/annrheumdis-2013-203586","article-title":"Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial","volume":"73","author":"Seror","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.survophthal.2025.06.009_bib159","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2665-9913(21)00152-1","article-title":"Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study","volume":"3","author":"Christ","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib160","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatol (Oxf)"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib161","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1016\/S2665-9913(23)00101-7","article-title":"Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"5","author":"Venhoff","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib162","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/annrheumdis-2021-221865","article-title":"Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"81","author":"Cid","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib163","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.semarthrit.2018.04.004","article-title":"Ustekinumab for refractory giant cell arteritis: a prospective 52-week trial","volume":"48","author":"Conway","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.survophthal.2025.06.009_bib164","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/acr.24200","article-title":"Ustekinumab for the treatment of giant cell arteritis","volume":"73","author":"Matza","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.survophthal.2025.06.009_bib165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/rheumatology\/keab280","article-title":"Steroid-sparing effect of anakinra in giant-cell arteritis: a case series with clinical, biological and iconographic long-term assessments","volume":"61","author":"Deshayes","year":"2021","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.survophthal.2025.06.009_bib166","article-title":"The meteoritics trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis: study protocol for a randomized, double-blind, placebo-controlled","author":"Kreis","year":"2023","journal-title":"Parallel Group Phase II Study"},{"issue":"5","key":"10.1016\/j.survophthal.2025.06.009_bib167","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S2665-9913(21)00038-2","article-title":"Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial","volume":"3","author":"Stone","year":"2021","journal-title":"Lancet Rheuma"},{"issue":"3","key":"10.1016\/j.survophthal.2025.06.009_bib168","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.survophthal.2025.06.009_bib169","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.survophthal.2025.06.009_bib170","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.survophthal.2025.06.009_bib171","article-title":"Aspirin as adjunctive treatment for giant cell arteritis","volume":"2014","author":"Mollan","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T18:03:45Z","timestamp":1768845825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625725001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":171,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0039625725001031"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.06.009","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in diagnosing and treating giant cell arteritis: New hope for arteritic anterior ischemic optic neuropathy","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}